The strong beat and raised EPS guidance, combined with margin expansion and strategic divestiture, support a bullish read-through for RGEN. Monitor upcoming quarterly results for continued organic growth trajectory and Transformation Office execution, the reiterated 9%-13% organic revenue guide provides a clear benchmark.
Price Chart
Executive Summary
Repligen reported Q1 2026 adjusted EPS of $0.48, beating the $0.38 consensus by 26.3%, and revenue of $194M (+15% YoY, +11% organic) above the $192.2M estimate. The company raised its full-year adjusted EPS guidance to $1.97-$2.05 (from prior $1.92-$2.00) while reiterating 9%-13% organic revenue growth, signaling confidence in margin expansion and operational execution.
Key Financial Metrics
Key Facts
- Q1 2026 adjusted EPS $0.48 vs consensus $0.38 (+26.3% beat)
- Q1 2026 revenue $194M vs consensus $192.2M (+15% reported, +11% organic YoY)
- GAAP EPS $0.15 vs $0.10 YoY; adjusted EPS $0.48 vs $0.39 YoY (+23%)
- Adjusted operating margin expanded 160bps to 15.4% (from 13.8% YoY)
- Full-year 2026 adjusted EPS guidance raised to $1.97-$2.05 (from $1.92-$2.00)
- Full-year 2026 revenue guidance reiterated at $803M-$833M (9%-13% organic growth)
- Divested non-core Polymem business (2025 rev $7M, operating loss) to sharpen focus
- Cash and marketable securities $785M; operating cash flow $28.3M in Q1
Financial Impact
EPS beat of $0.10 vs consensus (+26%) and revenue beat of ~$1.8M (+0.9%)
Risk Factors
- GAAP EPS of $0.15 remains low due to $13.8M loss on sale of Polymem and $9.8M intangible amortization
- Organic growth guidance of 9%-13% implies deceleration from Q1's 11% organic pace
- China partnership and tariff exposure add execution and geopolitical risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3287476 |
Track record
16 reports on RGEN
4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +31.47% at T+60 after the Jul 22, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 6, 202610d ago 8-K Neutral 4/10 Entry $178.94 Now $162.78 −9.03% settles Feb 5
- Oct 30, 202617d ago 8-K Neutral 5/10 Entry $176.94 Now $162.78 −8.00% settles Jan 28
- Oct 27, 202620d ago 8-K Bullish 6/10 No price data
- Oct 27, 202620d ago Press Release Bullish 6/10 Entry $175.80 Now $162.78 −7.41% settles Jan 25
- Oct 15, 20264w ago Institutional Cluster Mixed 3/10 Entry $184.17 Now $162.78 −11.61% settles Jan 12
- Oct 7, 20265w ago SC 13G/A Bullish 5/10 Entry $167.22 Now $162.78 −2.66% settles Jan 4
- Oct 6, 20265w ago 8-K Bullish 6/10 Entry $174.86 Now $162.78 −6.91% settles Dec 31
- Oct 6, 20265w ago Press Release Bullish 6/10 Entry $174.86 Now $162.78 −6.91% settles Dec 31
- Aug 24, 202612w ago S-4 Neutral 6/10 Entry $181.69 Now $162.78 −10.41% settles Nov 18
- Jul 28, 202615w ago 8-K Bullish 7/10 Entry $145.34 to $180.01 Now $162.78 +12.00% ▲ +23.85% +19.50% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers